ARS Pharmaceuticals, Inc. (SPRY)
4.11
-0.04
(-0.96%)
USD |
NASDAQ |
Sep 18, 16:00
4.19
+0.08
(+1.95%)
After-Hours: 18:28
ARS Pharmaceuticals Price : 4.11 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 4.26 | 4.30 | 4.12 | 4.15 | 1.873M |
| Sep 16, 2026 | 4.25 | 4.365 | 4.125 | 4.165 | 1.452M |
| Sep 15, 2026 | 4.50 | 4.50 | 4.220 | 4.25 | 2.776M |
| Sep 14, 2026 | 4.80 | 4.90 | 4.455 | 4.50 | 2.167M |
| Sep 11, 2026 | 5.13 | 5.19 | 4.73 | 4.76 | 2.574M |
| Sep 10, 2026 | 5.20 | 5.22 | 5.02 | 5.06 | 1.091M |
| Sep 09, 2026 | 5.35 | 5.38 | 5.215 | 5.23 | 874546.0 |
| Sep 08, 2026 | 5.515 | 5.535 | 5.305 | 5.39 | 1.087M |
| Sep 04, 2026 | 5.60 | 5.70 | 5.54 | 5.62 | 852848.0 |
| Sep 03, 2026 | 5.86 | 5.90 | 5.605 | 5.67 | 1.088M |
| Sep 02, 2026 | 5.86 | 6.00 | 5.745 | 5.82 | 1.197M |
| Sep 01, 2026 | 6.08 | 6.08 | 5.74 | 5.77 | 1.358M |
| Aug 31, 2026 | 5.87 | 6.09 | 5.615 | 6.00 | 1.985M |
| Aug 28, 2026 | 6.00 | 6.03 | 5.855 | 5.89 | 1.190M |
| Aug 27, 2026 | 6.03 | 6.12 | 5.89 | 6.03 | 1.191M |
| Aug 26, 2026 | 5.70 | 6.09 | 5.67 | 6.03 | 1.164M |
| Aug 25, 2026 | 5.40 | 5.76 | 5.39 | 5.72 | 1.716M |
| Aug 24, 2026 | 5.40 | 5.46 | 5.20 | 5.35 | 1.937M |
| Aug 21, 2026 | 5.52 | 5.60 | 5.465 | 5.505 | 1.268M |
| Aug 20, 2026 | 6.30 | 6.35 | 5.50 | 5.505 | 2.114M |
| Aug 19, 2026 | 6.42 | 6.58 | 6.35 | 6.38 | 1.213M |
| Aug 18, 2026 | 6.12 | 6.52 | 6.12 | 6.30 | 1.945M |
| Aug 17, 2026 | 5.62 | 6.285 | 5.575 | 6.24 | 2.505M |
| Aug 14, 2026 | 5.10 | 5.84 | 5.00 | 5.65 | 5.046M |
| Aug 13, 2026 | 6.08 | 6.19 | 5.90 | 6.10 | 1.979M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Passage Bio, Inc. | 4.70 |
| Vertex Pharmaceuticals, Inc. | 508.26 |
| Capricor Therapeutics, Inc. | 9.07 |
| Kyntra Bio, Inc. | 6.99 |
| Zentalis Pharmaceuticals, Inc. | 3.11 |
Price Related Metrics
| PS Ratio | 3.484 |
| PEG Ratio | -0.0055 |
| Price to Book Value | 32.66 |
| Earnings Yield | -52.87% |
| Market Cap | 408.69M |
| PEGY Ratio | -0.0055 |